Monitoring immunoglobulin heavy chain and T-cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid leukemia.

Zhong, Ling; Chen, Jiao; Huang, Xiaobing; Li, Yanxing; Jiang, Tao

Zhong, Ling; Chen, Jiao; Huang, Xiaobing; Li, Yanxing; Jiang, Tao.

Afiliação

Zhong L; Department of Clinical Laboratory, Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China.
Chen J; Department of Hematology, Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China.
Huang X; Department of Hematology, Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China.
Li Y; Department of Clinical Laboratory, Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China.
Jiang T; Department of Hematology, Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, P.R. China.

Oncol Lett ; 16(2): 2279-2288, 2018 Aug.

Article em En | MEDLINE | ID: mdl-30008930

Palavras-chave

T-cell receptor gene; circulating tumor DNA; immunoglobulin heavy chain; minimal residual disease; rearrangement

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article